Both sales and margin recovery are on track
业绩略超预期,首次披露EBIT Margin彰显后市信心
Solid margin and attractive valuation; wait for top-line recovery
3Q24 earnings below expectations due to margin contraction
3QFY23 margin beat on cost control; Upgrade to BUY
BYD Company (1211 HK) 4Q22 beat; FY23E margins likely overestimated
FY22 net margins better than expected
–Proactive competitive strategy may weigh on nearterm margin but benefit LT growth
Recent sell-off overdone; Positive on investments and margin recovery in FY24-25E
Fair guidance but decent inventory and margin